Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

471
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.9K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.9K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

397
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
397
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

1.8K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.8K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

687
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
687

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/ SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same author

Self-testing and clinical outcomes in Black and White patients on warfarin for atrial fibrillation or venous thromboembolism.

Research and practice in thrombosis and haemostasis·2026
Same author

Practice patterns of DOAC high-intensity period following parenteral lead-in treatment for venous thromboembolism.

Journal of thrombosis and thrombolysis·2026
Same author

Interhospital variation in Medicare spending for infections after coronary artery bypass grafting and surgical aortic valve replacement.

JTCVS open·2026
Same author

Multilevel Stewardship Intervention for Use of Anticoagulation-Antiplatelet Therapy.

JAMA internal medicine·2026
Same author

Implementation evaluation of an inpatient digital dashboard for direct oral anticoagulant surveillance.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Related Experiment Video

Updated: Apr 16, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.5K

Engaging with quality improvement in anticoagulation management.

Geoffrey D Barnes1, Eva Kline-Rogers

  • 1University of Michigan Cardiovascular Center (UM CVC), Domino's Farms, Lobby A, MCORRP, 24 Frank Lloyd Wright Dr., Ann Arbor, MI, 48106, USA, gbarnes@umich.edu.

Journal of Thrombosis and Thrombolysis
|March 17, 2015
PubMed
Summary

Improving anticoagulation management is crucial for balancing treatment benefits against bleeding risks. Quality improvement programs help providers assess performance and enhance patient safety with anticoagulants.

More Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.5K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.8K

Related Experiment Videos

Last Updated: Apr 16, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.5K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.5K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.8K

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Healthcare Management

Background:

  • Anticoagulants prevent thrombosis but carry risks of major bleeding and death.
  • Balancing anticoagulant benefits with bleeding risks is a key challenge in patient care.
  • Quality care measures are essential for evaluating anticoagulation management systems.

Purpose of the Study:

  • To review the rationale for quality improvement in anticoagulation management.
  • To present examples of successful quality improvement programs.
  • To detail potential quality measures and resources for anticoagulation providers.

Main Methods:

  • Literature review summarizing existing quality improvement strategies.
  • Inclusion of interventions for both warfarin and direct oral anticoagulants.
  • Description of various quality measures and provider resources.

Main Results:

  • Quality improvement activities enable performance assessment and targeted interventions.
  • Established quality measures focus on patient outcomes and provider processes.
  • Examples of interventions applicable to both traditional and novel anticoagulants are provided.

Conclusions:

  • Quality improvement is vital for optimizing anticoagulation therapy.
  • Implementing quality measures can mitigate risks and improve patient outcomes.
  • Resources are available to support providers in initiating quality improvement processes.